Jan 29, 2025
Xeljanz, known as tofacitinib, faces litigation due to alleged health risks like blood clots and cardiovascular issues. Plaintiffs claim Pfizer didn't adequately warn users. The lawsuits are evolving, with some significant compensations awarded. If you or a loved one were affected, understanding your rights is essential. Pursuing legal action requires...
4 Min Read